These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33436457)

  • 21. An audit of structured diabetes care in a rural general practice.
    Ackermann EW; Mitchell GK
    Med J Aust; 2006 Jul; 185(2):69-72. PubMed ID: 16842058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care.
    Selak V; Elley CR; Bullen C; Crengle S; Wadham A; Rafter N; Parag V; Harwood M; Doughty RN; Arroll B; Milne RJ; Bramley D; Bryant L; Jackson R; Rodgers A
    BMJ; 2014 May; 348():g3318. PubMed ID: 24868083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular secondary prevention in high-risk patients: a randomized controlled trial sub-study.
    Jakobsson S; Irewall AL; Bjorklund F; Mooe T
    BMC Cardiovasc Disord; 2015 Oct; 15():125. PubMed ID: 26466804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of risk assessment and management programme for hypertension on clinical outcomes and cardiovascular disease risks after 12 months: a population-based matched cohort study.
    Yu EY; Wan EY; Wong CK; Chan AK; Chan KH; Ho SY; Kwok RL; Lam CL
    J Hypertens; 2017 Mar; 35(3):627-636. PubMed ID: 27861244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tackling obesity in areas of high social deprivation: clinical effectiveness and cost-effectiveness of a task-based weight management group programme - a randomised controlled trial and economic evaluation.
    McRobbie H; Hajek P; Peerbux S; Kahan BC; Eldridge S; Trépel D; Parrott S; Griffiths C; Snuggs S; Myers Smith K
    Health Technol Assess; 2016 Oct; 20(79):1-150. PubMed ID: 27802843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What components of chronic care organisation relate to better primary care for coronary heart disease patients? An observational study.
    van Lieshout J; Frigola Capell E; Ludt S; Grol R; Wensing M
    BMJ Open; 2012; 2(4):. PubMed ID: 22904332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Change in calculated cardiovascular risk due to guideline revision: A cross-sectional study in the Netherlands.
    Luymes CH; de Ruijter W; Poortvliet RK; Putter H; van Duijn HJ; Numans ME; Drewes YM; Blom JW; Assendelft WJ
    Eur J Gen Pract; 2015; 21(4):217-23. PubMed ID: 26230039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved unhealthy lifestyle habits in patients with high cardiovascular risk: results from a structured lifestyle programme in primary care.
    Lönnberg L; Ekblom-Bak E; Damberg M
    Ups J Med Sci; 2019 Apr; 124(2):94-104. PubMed ID: 31063003
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-term, telephone-based follow-up after stroke and TIA improves risk factors: 36-month results from the randomized controlled NAILED stroke risk factor trial.
    Ögren J; Irewall AL; Söderström L; Mooe T
    BMC Neurol; 2018 Sep; 18(1):153. PubMed ID: 30241499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient characteristics and reasons for discontinuation in a cardiovascular risk management programme in The Netherlands.
    Smits GHJM; van Doorn S; Bots ML; Hollander M
    BMC Prim Care; 2024 Feb; 25(1):55. PubMed ID: 38342918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of lifestyle intervention improve cardiovascular disease risk factors in community-based menopausal transition and early postmenopausal women in China.
    Wu L; Chen R; Ma D; Zhang S; Walton-Moss B; He Z
    Menopause; 2014 Dec; 21(12):1263-8. PubMed ID: 24781851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective meta-analysis of trials comparing fixed dose combination based care with usual care in individuals at high cardiovascular risk: the SPACE Collaboration.
    Webster R; Patel A; Billot L; Cass A; Burch C; Neal B; Usherwood T; Thom S; Poulter N; Stanton A; Bots ML; Grobbee DE; Prabhakaran D; Reddy KS; Field J; Bullen C; Elley CR; Selak V; Rafter N; Wadham A; Berwanger O; Rodgers A;
    Int J Cardiol; 2013 Dec; 170(1):30-5. PubMed ID: 24144927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Which practice characteristics are associated with the quality of cardiovascular disease prevention in European primary care?
    Ludt S; Campbell SM; Petek D; Rochon J; Szecsenyi J; van Lieshout J; Wensing M; Ose D
    Implement Sci; 2013 Mar; 8():27. PubMed ID: 23510482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).
    ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
    JAMA; 2002 Dec; 288(23):2998-3007. PubMed ID: 12479764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sex differences in cardiovascular risk management for people with diabetes in primary care: a cross-sectional study.
    de Jong M; Vos RC; de Ritter R; van der Kallen CJ; Sep SJ; Woodward M; Stehouwer CD; Bots ML; Peters SA
    BJGP Open; 2019 Jul; 3(2):. PubMed ID: 31366676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Mediterranean diet education versus posted leaflet on dietary habits and serum cholesterol in a high risk population for cardiovascular disease.
    Bemelmans WJ; Broer J; de Vries JH; Hulshof KF; May JF; Meyboom-De Jong B
    Public Health Nutr; 2000 Sep; 3(3):273-83. PubMed ID: 10979147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimated cardiovascular relative risk reduction from fixed-dose combination pill (polypill) treatment in a wide range of patients with a moderate risk of cardiovascular disease.
    Lafeber M; Webster R; Visseren FLj; Bots ML; Grobbee DE; Spiering W; Rodgers A;
    Eur J Prev Cardiol; 2016 Aug; 23(12):1289-97. PubMed ID: 26743587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-soluble-fiber foods in conjunction with a telephone-based, personalized behavior change support service result in favorable changes in lipids and lifestyles after 7 weeks.
    Kris-Etherton PM; Taylor DS; Smiciklas-Wright H; Mitchell DC; Bekhuis TC; Olson BH; Slonim AB
    J Am Diet Assoc; 2002 Apr; 102(4):503-10. PubMed ID: 11985406
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.